No content found

Monday, January 17 | 4:00PM - 8:00PM
Registration
Arrival and Registration
Room: Longs Peak Foyer


Monday, January 17 | 6:00PM - 8:00PM
Welcome Mixer

Room: Longs Peak Foyer
No registration fees are used to fund alcohol served at this function.

Tuesday, January 18 | 7:00AM - 8:00AM
Breakfast

Room: Colorado Rockies Ballroom


Tuesday, January 18 | 8:00AM - 11:00AM
Plenary AM
Inflammation and Innate Immunity in Viral Infections
Room: Longs Peak


Siddharth Balachandran, Fox Chase Cancer Center, USA
Mechanisms of Influenza Virus-Induced Cell Death

Lisa P. Daley-Bauer, Emory University, USA
Combined Deficiency in Caspase-8 and RIPK3

Coffee Break

Catherine A. Blish, Stanford University School of Medicine, USA
Innate Immune Dysfunction in COVID-19

Ferrin Antony, Auburn University, USA
Short Talk: IL-27 Modulates Macrophage Metabolism during HSV-1 Infection to Regulate Immunopathology

Justin J. Frere, NYU Langone, USA
Short Talk: SARS-CoV-2 Infection Results in Sustained Inflammation in the Brain Following Viral Clearance

Jamie M. Strampe, Boston University, USA
Short Talk: Biomarkers of Disease Outcome in Lassa Fever

Tuesday, January 18 | 8:00AM - 11:00AM
Plenary AM
Beyond Acute Disease: Consequences of Respiratory Virus Infections
This session is from Respiratory Viruses

Room: Grays Peak


Jie Sun, University of Virginia, USA
Immune Mediated Lung Damage

Andrew E. Vaughan, University of Pennsylvania, USA
Chronic Post-Viral Effects on Lung Structure

Carolina B. López, Washington University School of Medicine, USA
Impact of Defective Viral Genomes on Respiratory Syncytial Virus Clinical Outcomes

Italo A. Castro, Washington University School of Medicine, USA
Short Talk: Reactivation of Persistent Paramyxovirus Infection Increases Chronic Lung Pathology In Mice

Sydney R. Stein, National Institutes of Health, USA
Short Talk: SARS-CoV-2 Infection and Persistence Across the Human Body and Brain

Jessica Rubens, Johns Hopkins Bloomberg School of Public Health, USA
Short Talk: Novel Recombinant Measles Virus Vaccine in Rhesus Macaques


Tuesday, January 18 | 11:00AM - 5:00PM
On Own for Lunch



Tuesday, January 18 | 11:00AM - 1:00PM
Poster Setup

Room: Colorado Rockies Ballroom


Tuesday, January 18 | 1:00PM - 10:00PM
Poster Viewing

Room: Colorado Rockies Ballroom


Tuesday, January 18 | 2:30PM - 4:30PM
Workshop
Workshop 1: Innate Immunity in Viral Infections
Room: Longs Peak


Adriana Forero, Ohio State University, USA
MEF2A is a Regulator of Interferon-Mediated Inflammation

Chiara E. Geyer, Amsterdam UMC, Netherlands
Anti-SARS-CoV-2 IgG of Severely Ill COVID-19 Patients Induces Hyper-Inflammation that can be Specifically Counteracted by FDA/EMA-Approved Small Molecule Inhibitors

Hannah Itell, Fred Hutch / University of Washington, USA
Defining the Cell-Intrinsic Effectors of the Antiviral Interferon Response against HIV in CD4+ T cells

Tianyang Mao, Yale University, USA
A Stem-Loop RNA RIG-I Agonist Protects against Acute and Chronic SARS-CoV-2 Infection in Mice

Christine Nelson, NIAID, National Institutes of Health, USA
Opposing Effects of IL-10 and IFNg During SARS-CoV-2 Infection in Non-Human Primates

Fabian Pott, Charité Universitaetsmedizin Berlin, Germany
Single-Cell Analysis of Arthritogenic Alphavirus-Infected Human Synovial Fibroblasts Uncovers a Switch from Induction to Repression of Innate Immunity in Infected Cells

Ashley Zani, Ohio State University, USA
Gasdermin D Deficiency Limits the Severity of Influenza in Mice

Tuesday, January 18 | 2:30PM - 4:30PM
Workshop
Workshop 1: SARS-CoV-2/COVID-19
This session is from Respiratory Viruses
Room: Grays Peak


Matthew Gartner, Peter Doherty Institute for Infection and Immunity, Australia
Differential mechanisms of SARS-CoV-2 entry in stem cell derived lung and cardiac cells

Margaret Mills, University of Washington, USA
Predicting Infectivity: Comparing Four PCR-based Assays to Detect Culturable SARS-CoV-2 in Clinical Specimens

Erica Normandin, Broad Institute, USA
SARS-CoV-2 tropism and compartmentalization in fatal COVID-19

Lauren B. Rodda, University of Washington, USA
Impact of Previous SARS-CoV-2 Infection on the Immune Response to COVID-19 Vaccination

Caitlin Stoddard, Fred Hutchinson Cancer Research Center, USA
Distinct High-Resolution SARS-CoV-2 Antibody Responses Among Infected Mother-Infant Pairs in Nairobi, Kenya

Jacob S. Yount, Ohio State University, USA
Interferon Induced Transmembrane Protein 3 (IFITM3) Limits Lethality of SARS-CoV-2 in Mice

Michael G. Joyce, Henry M. Jackson Foundation / Walter Reed Army Institute of Research, USA
SARS-CoV-2 Ferritin Nanoparticle Vaccines Elicit Broad SARS Coronavirus Immunogenicity

Mireille Farjo, University of Illinois, Urbana-Champaign, USA
Within-Host Evolutionary Dynamics of SARS-CoV-2 in Humans Captured by Dense Longitudinal Sampling


Tuesday, January 18 | 4:30PM - 5:00PM
Coffee Available

Room: Longs Peak Foyer


Tuesday, January 18 | 5:00PM - 7:00PM
Plenary PM (JT)
Immunity and Respiratory Viruses: Good and Bad (Joint)
Room: Grays/Longs Peaks


Katelyn M. Gostic, University of Chicago, USA
Order matters: Imprinting and Other Forms of Path-Dependence Shape Cross-Protective Immune Memory

Peter J.M. Openshaw, Imperial College London, UK
Mucosal Immunity to Respiratory Viruses

Ali H. Ellebedy, Washington University School of Medicine, USA
Tracking Human Immune Responses to Influenza Vaccines across Anatomical Compartments

Andreas Wack, Francis Crick Institute, UK
Types I and III Interferons in Pathogenesis and Repair

Keaton M. Crosse, New York University, USA
Short Talk: The ELF1 Transcription Factor Mediates an Interferon-Independent Pan-Antiviral Immune Response

In Su Cheon, Mayo Clinic, USA
Short Talk: Exuberant Pulmonary T cells Compromise Lung Function Post-Acute COVID-19

Tuesday, January 18 | 7:00PM - 8:00PM
Social Hour with Lite Bites

Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Tuesday, January 18 | 7:30PM - 10:00PM
Posters
Poster Session 1
Room: Colorado Rockies Ballroom


Wednesday, January 19 | 7:00AM - 8:00AM
Breakfast

Room: Colorado Rockies Ballroom


Wednesday, January 19 | 8:00AM - 11:00AM
Plenary AM
Human Immunity in Blood and Tissues
Room: Longs Peak


Katherine Kedzierska, University of Melbourne, Australia
CD8+ T Cell Immunity in Viral Infection and Vaccination

Donna L. Farber, Columbia University Medical Center, USA
Anti-Viral Immunity in Human Tissues

Coffee Break

Speaker to be Announced

Daniela Weiskopf, La Jolla Institute for Immunology, USA
Short Talk: Low Dose mRNA-1273 COVID-19 Vaccine Generates Durable Memory Enhanced by Crossreactive T Cells

Robert Mettelman, St Jude Children/'s Research Hospital, USA
Short Talk: Defining Cellular Correlates of Protection to Influenza Virus Across Human Cohorts

Julia Niessl, Karolinska Institutet, Sweden
Short Talk: Functional Tissue-Resident Memory CD8+ T Cells Specific for SARS-CoV-2 Reside in Unexposed Oropharyngeal Lymphoid Tissue

Wednesday, January 19 | 8:00AM - 11:00AM
Plenary AM
New Approaches to Studying Respiratory Viruses I
This session is from Respiratory Viruses
Room: Grays Peak


Seema Lakdawala, University of Pittsburgh School of Medicine, USA
Microscopy to Study Viral Transport within Infected Cells

Edward Hutchinson, University of Glasgow, UK
Hybrid Genes and Chimeric Proteins

Susanne Herold, University of Giessen Lung Center, Germany
Organoid Modeling to Study the Pathomechanisms of Viral Lung Infection

William E. Matchett, University of Minnesota, USA
Short Talk: Influenza A Virus Inducible Cre Recombinase Knock-In Mouse

Mallory M. Thomas, Montana State University, USA
Short Talk: Highly Variable Influenza A Viral Burst Size from High-throughput Single Cell Analysis using Drop-based Microfluidics

Daniel Lingwood, Havard Medical School, USA
Short Talk: Coordinated IL-6 trans Signaling Provides Viral Immunity at the Respiratory Surface


Wednesday, January 19 | 11:00AM - 5:00PM
On Own for Lunch



Wednesday, January 19 | 11:00AM - 1:00PM
Poster Setup

Room: Colorado Rockies Ballroom


Wednesday, January 19 | 1:00PM - 10:00PM
Poster Viewing

Room: Colorado Rockies Ballroom


Wednesday, January 19 | 2:30PM - 4:30PM
Workshop
Workshop 2: Adaptive Immunity in Viral Infections
Room: Longs Peak


J. Scott Hale, University of Utah, USA
De Novo Methylation Enforces Long-Term Lineage-Specific Programing of T Follicular Helper and T Helper 1 Memory Cells

Michael A. Farrar, University of Minnesota, USA
Interferon Gene-Signature Tregs in Viral Infection

Julianna Han, The Scripps Research, USA
A Chimeric HA UIV Elicits Multi-Pronged Polyclonal Antibody Responses to Conserved Head and Stem Epitopes on HA

Daniel F. Luque Duque, University of Leeds, UK
Stochastic Modelling of TCR-Epitope Recognition in the Context of Cross-Reactivity

Mikhail Pogorelyy, St. Jude Children's Research Hospital, USA
Prediction of Immunodominant CD4+ SARS-CoV-2 Epitopes with TCR Repertoire Sequencing Data

Katherine G. Nabel, Harvard Medical School, USA
Structural Basis for Continued Antibody Evasion by the SARS-CoV-2 Receptor-Binding Domain

Ida E M Uddback, University of Copenhagen, Denmark
Resident Memory CD8+ T Cells in the Respiratory Tract Limits Transmission of Viruses

David LV Bauer, Francis Crick Institute, UK
Close Encounters of the Third Kind: Comparison of Vaccine-Boosted vs. Delta Infection-Boosted Immunity to SARS-CoV-2 Variants of Concern

Wednesday, January 19 | 2:30PM - 4:30PM
Workshop
Workshop 2: Transmission
This session is from Respiratory Viruses
Room: Grays Peak


Chris Brooke, University of Illinois at Urbana-Champaign, USA
Longitudinal Sampling of SARS-CoV-2 Infection Reveals Substantial Heterogeneity in Infectious Virus Shedding and Effects of Variants and Vaccination

Andrea French, University of Pittsburgh, USA
Secondary Infection with Streptococcus Pneumoniae Decreases Influenza Virus Replication and Severe Disease is Linked to Reduced Airborne Transmission

Joshua D. Powell, USDA-ARS, USA
Targeted Mutagenesis Provides Molecular Insight Into Key Changes in the Hemagglutinin Gene that Impacted Transmission of Human H3N2 Influenza A Virus in Swine

Vineet D. Menachery, University of Texas Medical Branch, USA
Nucleocapsid Mutations in SARS-CoV-2 Variants Augment Pathogenesis and Transmission

Nicole C. Rockey, University of Pittsburgh, USA
Pre-existing Heterosubtypic Immunity Provides a Barrier to Airborne Transmission of Influenza Viruses

Frances K. Shepherd, University of Minnesota, USA
Unraveling Paramyxovirus Transmission Among Natural Hosts with the “Dirty Mouse” Model System

Emily Bruce, University of Vermont, USA
Measuring Infectious SARS-CoV-2 in Clinical Samples Reveals Higher Viral Titer: RNA Ratio for Delta and Epsilon vs Alpha Variants


Wednesday, January 19 | 4:30PM - 5:00PM
Coffee Available

Room: Longs Peak Foyer


Wednesday, January 19 | 5:00PM - 7:00PM
Plenary PM
T Cells, B Cells and their Receptors
Room: Longs Peak


Paul G. Thomas, St. Jude Children's Research Hospital, USA
Specificity of the CD8 T Cell Compartment in Viral Infections

Bryan Briney, The Scripps Research Institute, USA
Diversity in the Human Antibody Repertoire

Dirk Hans Busch, Technical University Munich, Germany
CD8+ T Cells in CMV Infection

Sophie A. Valkenburg, University of Hong Kong, Hong Kong
The Coordinated B and T Cell Response in Influenza Vaccination

Carolien van de Sandt, University of Melbourne at the Peter Doherty Institute, Australia
Short Talk: Molecular and Functional Mechanisms Underlying Age-Related Changes in Influenza Virus-Specific CD8+ T Cells Across Human Lifespan

Davide Angeletti, University of Gothenburg, Sweden
Short Talk: Single-Cell BCR and Transcriptome Analysis After Influenza Infection Reveals Spatiotemporal Dynamics of Antigen-Specific B Cells

Wednesday, January 19 | 5:00PM - 7:00PM
Plenary PM
Novel Insights into Respiratory Virus Biology
This session is from Respiratory Viruses
Room: Grays Peak


Andrew B. Ward, The Scripps Research Institute, USA
Monitoring Antibody Responses to Influenza and Coronaviruses using Electron Microscopy

Ryan A. Langlois, University of Minnesota, USA
Virus-Cell Interactions in vivo

Jennifer M. Lund, Fred Hutchinson Cancer Research Center, USA
T Cell Phenotypes in the Antiviral Response

Christopher Chiu, Imperial College London, UK
Lessons from Human Challenge Infection with Respiratory Viruses

Alistair B. Russell, University of California, San Diego, USA
Short Talk: A Comprehensive Analysis of Defective Influenza A Viruses Using Artificial Libraries

Anice Lowen, Emory University School of Medicine, USA
Short Talk: Influenza A Virus Reassortment in Swine Produces Spatially Heterogenous Within-Host Viral Populations


Wednesday, January 19 | 7:00PM - 8:00PM
Social Hour with Lite Bites

Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Wednesday, January 19 | 7:30PM - 10:00PM
Posters
Poster Session 2
Room: Colorado Rockies Ballroom


Thursday, January 20 | 7:00AM - 8:00AM
Breakfast

Room: Colorado Rockies Ballroom


Thursday, January 20 | 8:00AM - 11:00AM
Plenary AM (JT)
Translational and Developmental Aspects of Antibodies (Joint)

Room: Grays/Longs Peaks


Galit Alter, MIT and Harvard University, USA
Systems Serology to Characterize Antibody Responses

Alina Baum, Regeneron Pharmaceuticals, USA
Antibodies to Respiratory Viruses– Successes and Challenges

Coffee Break

J D. Bloom, Fred Hutchinson Cancer Research Center, USA
Interpreting the Evolution of SARS-CoV-2

Garrett Rappazzo, Adimab LLC, USA
Short Talk: Profiling Memory B Cell Antibody Repertoires to Human Metapneumovirus F Glycoprotein in its Prefusion Conformation

Chelsea M. Crooks, University of Wisconsin-Madison, USA
Short Talk: Comparison of Infection Dynamics and Antibody Repertoire in Rhesus Macaques with Serial Flavivirus Exposures

Kali Florence Crofts, Wake Forest School of Medicine, USA
Short Talk: Analysis of R848 as an Adjuvant to Improve Inactivated Influenza Vaccine Immunogenicity in Elderly Nonhuman Primates

Thursday, January 20 | 11:00AM - 5:00PM
On Own for Lunch



Thursday, January 20 | 4:30PM - 5:00PM
Coffee Available

Room: Longs Peak Foyer


Thursday, January 20 | 5:00PM - 7:00PM
Plenary PM
Novel Approaches to Anti-Viral Vaccines
Room: Longs Peak


Florian Krammer, Icahn School of Medicine at Mount Sinai, USA
Targets for Broadly Protective Influenza Virus Vaccines

Andrea J. Sant, University of Rochester Medical Center, USA
Influenza Specific CD4 T Cell Responses to Vaccination and Infection

Gary J. Nabel, Sanofi, USA
Innovation in Antibody Structure and Design

Stacey Lynne Schultz-Cherry, St. Jude Children's Research Hospital, USA
Vaccinating Vulnerable Populations

Thursday, January 20 | 5:00PM - 7:00PM
Plenary PM
Prevention and Treatment Strategies: Vaccines and Antivirals
This session is from Respiratory Viruses
Room: Grays Peak


Nevan J. Krogan, University of California, San Francisco, USA
Host Factors as Antiviral Targets

Kathleen M. Neuzil, University of Maryland, USA
Comparing and Contrasting COVID-19 Vaccine Platforms

Kanta Subbarao, WHO Collaborating Centre for Reference and Research on Influenza, Australia
Improving Influenza Vaccines

Kena Swanson, Pfizer Inc., USA
RSV Vaccines – Lessons Learned from the COVID-19 Experience with Respect to Pediatric Vaccines

Yaniv Erlich, Eleven Therapeutics, UK
Short Talk: Genome Wide Screen of SARS-CoV-2 Identifies Hyper-Potent siRNAs as Self-Administered Nasal Prophylactics


Thursday, January 20 | 7:00PM - 7:15PM
Plenary
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
This session is from Respiratory Viruses
Room: Grays Peak


Thursday, January 20 | 7:00PM - 7:15PM
Plenary
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Longs Peak


Thursday, January 20 | 7:15PM - 8:00PM
Social Hour with Lite Bites

Room: Colorado Rockies Ballroom
No registration fees are used to fund alcohol served at this function.

Thursday, January 20 | 8:00PM - 9:00PM
Cash Bar

Room: Colorado Rockies Ballroom


Friday, January 21 | 8:29AM - 8:29AM
Departure



*Session Chair
†Invited, not yet responded.

No content found

No content found

No content found